Influx Healthtech Limited (NSE:INFLUX)

Market Cap	3.59B
Revenue (ttm)	1.05B
Net Income (ttm)	133.66M
Shares Out	23.15M
EPS (ttm)	7.36
PE Ratio	21.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	82,800
Average Volume	293,220
Open	155.00
Previous Close	158.05
Day's Range	154.00 - 164.00
52-Week Range	120.00 - 184.00
Beta	n/a
RSI	53.31
Earnings Date	n/a

About Triumph Group

Influx Healthtech Limited operates as a contract development and manufacturing organization that provides a range of healthcare products in India. The company offers ayurvedic and herbal formulations in form of tablets, capsules, powders, liquid orals, ointments, creams, lotions, and other applications; veterinary feed supplements in form of tablets, liquid orals, oral sprays, powders, bolus, gels, ointments, and creams for animals; and home care products, including bathroom cleaners, floor cleansers, phenyle liquids, and other household cleani...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2003
• Employees: 163
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INFLUX

Financial Performance

In 2024, Influx Healthtech's revenue was 1.05 billion, an increase of 4.89% compared to the previous year's 999.65 million. Earnings were 133.66 million, an increase of 20.11%.